Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort
Cognitive decline is a major non-motor symptom in Parkinson's disease (PD), often linked to brain atrophy. This study examines the relationship between cortical atrophy and age groups in predicting cognitive decline in PD over five years. 188 PD patients from the COPPADIS cohort were stratified by age: young (30-55 years, N = 47), middle-aged (56-65 years, N = 59), and older adults (66-75 years, N = 82). Baseline cortical volume was assessed using T1-weighted MRI, and cognitive decline was evaluated using the annual rate of change of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS). Parametric or non-parametric tests were applied to evaluate group differences. Main analyses consist of several multiple regression analyses to examine associations between baseline brain atrophy and cognitive decline by age group. Older adults exhibited significantly greater cognitive decline in comparison to the younger age groups in the three compose scores of the PDCRS -Fronto-subcortical (H(2) = 41.08, p < 0.001), Posterior Cortical (H(2) = 22.03, p < 0.001), and Total(H(2) = 41.13, p < 0.001). Higher educational level has a significant positive effect on older adults, specifically for working memory performance, delayed verbal memory and the fronto-subcortical composed score. Multiple regression models underscored the predictive value of the bilateral hippocampus, bilateral medial orbitofrontal cortex, right precuneus, and right isthmus cingulate gyrus, together with being an older adult or having a higher education. MRI measures, age, and education predict cognitive decline in PD. Longitudinal assessments are essential for refining atrophy-cognition correlations and optimizing patient stratification.
Authors
- Diego Santos‐García (ORCID: https://orcid.org/0000-0002-3126-5111)
- Carmen Solares (ORCID: https://orcid.org/0000-0001-6656-8836)
- Juan César Álvarez Carriles (ORCID: https://orcid.org/0000-0001-9585-6423)
- Pablo Franco‐Rosado (ORCID: https://orcid.org/0000-0002-7433-069X)
- Patricia Diaz‐Galvan (ORCID: https://orcid.org/0000-0001-6155-5585)
- Tania Álvarez-Avellón
- Manuel Menéndez‐González (ORCID: https://orcid.org/0000-0002-5218-0774)
- Pablo Mir
Institutions
- Universidad de Oviedo (ES)
- Instituto de Salud Carlos III (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Central de Asturias (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitario San Rafael (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Brain Imaging and Behavior
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1007/s11682-025-01031-8
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Consejería de Transformación Económica, Industria, Conocimiento y Universidades
- Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía
- Ministerio de Economía y Competitividad
- Ministerio de Ciencia e Innovación
- Universidad de Oviedo
- Instituto de Salud Carlos III